Quick Answer
Enveric Biosciences, Inc. reported Operating Income Loss of -$8.77 million for the year ending 2025.
- Enveric Biosciences, Inc. showed an increase of +8.9% in Operating Income Loss from 2024 to 2025.
- This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: -$981.3 thousand | Q2 2016: -$936.6 thousand | Q3 2016: -$1.29 million | Q1 2017: -$630.5 thousand | Q2 2017: -$3.51 million | Q3 2017: -$3.95 million | Q1 2018: -$1.37 million | Q2 2018: -$1.08 million | Q3 2018: $6.10 million | Q1 2019: -$1.30 million | Q2 2019: -$1.48 million | Q3 2019: -$1.57 million | Q1 2020: -$836.7 thousand | Q2 2020: -$767.5 thousand | Q3 2020: -$489.8 thousand | Q1 2021: -$6.76 million | Q2 2021: -$3.36 million | Q3 2021: -$3.52 million | Q1 2022: -$4.80 million | Q2 2022: -$4.71 million | Q3 2022: -$5.66 million | Q1 2023: -$4.86 million | Q2 2023: -$5.76 million | Q3 2023: -$3.45 million | Q1 2024: -$2.48 million | Q2 2024: -$1.90 million | Q3 2024: -$2.08 million | Q1 2025: -$2.19 million | Q2 2025: -$2.52 million | Q3 2025: -$1.87 million.
- Over the full 15 years of available data (2010 to 2025), Enveric Biosciences, Inc.'s Operating Income Loss has declined by 24,358.4%.
- Historical annual values: Fiscal year 2025: -$8.77 million | Fiscal year 2024: -$9.63 million | Fiscal year 2023: -$16.45 million | Fiscal year 2022: -$27.42 million | Fiscal year 2021: -$64.62 million | Fiscal year 2020: -$5.62 million | Fiscal year 2019: -$2.30 million | Fiscal year 2018: -$7.15 million | Fiscal year 2017: -$10.90 million | Fiscal year 2016: -$5.38 million | Fiscal year 2014: $32.8 thousand | Fiscal year 2013: $27.2 thousand | Fiscal year 2012: -$22.7 thousand | Fiscal year 2011: -$31.4 thousand | Fiscal year 2010: -$35.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: